KPWHRI volunteers help deliver free medical, dental, and optical care to attendees of the 4-day clinic.
Their work contributes to improved quality of care and better understanding of patients’ needs.
The NIH-sponsored trial will help inform decisions about vaccine approval for 12- to 17-year-olds.
Participant in KPWHRI trial receives world’s first-ever injection of investigational SchistoShield vaccination.
NIAID-sponsored study includes Seattle in test for benefits of mixing different vaccine types.
Kayne Mettert reflects on lived experience — and his drive to reduce stigma around mental health disorders.
An investigational vaccine developed by Moderna is being tested for safety and immune response in Seattle and 3 other cities.
Land Acknowledgment
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.